📖 Approx. 3 min
In this article, a medical industry M&A advisor explains from a practical perspective what issues arise when transitioning to a Specific Medical Corporation in business succession and medical M&A involving insurance designation. We will provide specific countermeasures based on the continuation/new acquisition of health insurance designation, tax incentives, and public interest requirements.
1. Industry Background of Insurance Designation and Becoming a Specific Medical Corporation
According to the Ministry of Health, Labour and Welfare’s Survey of Medical Institutions, the management environment for medical institutions, including those with insurance designation, has become increasingly severe in recent years due to complex factors such as revisions to medical fees, rising personnel costs, and the burden of equipment investment. Particularly from the perspective of continuing or newly acquiring health insurance designation, interest in third-party succession M&A is growing.
At the same time, transitioning to a Specific Medical Corporation is an important issue in medical M&A practice. By properly designing tax incentives and public interest requirements, a succession that benefits both the transferor and transferee can be achieved.
2. Key Practical Points
- Preparation: Organize the business flow, patient base, and equipment status specific to insurance designation, and clarify the transfer conditions.
- Business Valuation: Calculate an appropriate transfer price range based on the characteristics of the medical department. For insurance designation, the continuation or new acquisition of health insurance designation is key to the valuation.
- Design of Specific Medical Corporation Transition: Select the optimal scheme based on tax incentives and public interest requirements. Verification from tax, legal, and labor perspectives is also necessary.
- Partner Search & Matching: Select suitable transferee candidates from a nationwide network based on medical department characteristics. Carefully coordinate desired conditions.
- Due Diligence: Conduct thorough investigations from financial, legal, labor, and medical practice perspectives. Also confirm licenses, permits, and facility standards specific to insurance designation.
- Final Agreement & Closing: Conclude the final agreement, including representations and warranties, and indemnity clauses. Proceed with license/permit transfer and staff notification in parallel.
3. Specific Considerations for Insurance Designation
In M&A of medical institutions with insurance designation, the continuation or new acquisition of health insurance designation holds the key to successful succession. Numerous individual issues exist depending on the characteristics of the medical department, such as the continuity of the patient base, maintaining employment for staff (doctors, nurses, allied health professionals), equipment status and renewal plans, and maintaining/acquiring facility standards.
Furthermore, strategic design based on market characteristics unique to insurance designation, such as the composition of insured and self-pay medical services, the status of regional medical collaboration, and relationships with nearby competing medical institutions, is crucial. Leveraging our track record in supporting insurance designation successions, our company provides practical support from an industry-specific perspective.
4. Practical Details of Becoming a Specific Medical Corporation
Transitioning to a Specific Medical Corporation is an area requiring specialized consideration in medical M&A. Design based on tax incentives and public interest requirements is the key to success.
- Confirmation of Related Laws and Practical Standards: Preparation based on the Medical Care Act, tax laws, and labor laws
- Collaboration with Experts: Cooperation with certified public accountants, tax accountants, lawyers, and labor and social security attorneys
- Risk Assessment: Identification of potential risks and formulation of countermeasures
- Consensus Building Between Parties: Designing mutually agreeable conditions for both transferor and transferee
- Proper Documentation: Clear specification in the basic agreement and final contract
Frequently Asked Questions
Q. What documents are required for consultation?
A. It would be helpful if you could prepare financial statements for the last three fiscal years, patient volume trends, staff composition, equipment list, and lease agreements (if applicable) in advance. We will receive them after the NDA is signed.
Q. What is the market price range for transferring an insurance designation?
A. For insurance designation, the continuation or new acquisition of health insurance designation is the valuation axis. For clinics without beds, it’s typically 0.5 to 1.5 times annual revenue, and for hospitals with beds, an EBITDA multiple of 3 to 7 times is a guideline. We will provide details in a free preliminary assessment.
Q. What are the points to note when proceeding with the transition to a Specific Medical Corporation?
A. Prior design based on tax incentives and public interest requirements is essential. Seamless execution of practical tasks through collaboration with experts is key to success.
Q. Will staff and patients know about the consultation?
A. Information disclosure is limited after the NDA is signed, and no disclosure to related parties will occur before the final agreement. We ensure strict confidentiality.
Related Columns
- Complete Guide to Hospital and Medical Corporation Business Succession M&A
- The Full Picture of Clinic Sales and Transfers: Price Trends, Procedures, and Considerations
- How to Proceed with Medical M&A and Hospital Succession | Duration, Costs, and Considerations
- Tax Schemes for Medical Corporation M&A: Key Issues for Experts to Address
For consultations on Specific Medical Corporation Transition and Insurance Designation, contact M&A Medical
Strict Confidentiality – Free Initial Consultation – Success Fee Basis